Acorah Software Products - Accounts Production 16.1.300 false true 31 May 2023 1 June 2022 false 1 June 2023 31 May 2024 31 May 2024 13406862 Mr Max Baumann Mr Ali Pashazadeh Monadjemi iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 13406862 2023-05-31 13406862 2024-05-31 13406862 2023-06-01 2024-05-31 13406862 frs-core:CurrentFinancialInstruments 2024-05-31 13406862 frs-core:Non-currentFinancialInstruments 2024-05-31 13406862 frs-core:ShareCapital 2024-05-31 13406862 frs-core:RetainedEarningsAccumulatedLosses 2024-05-31 13406862 frs-bus:PrivateLimitedCompanyLtd 2023-06-01 2024-05-31 13406862 frs-bus:FilletedAccounts 2023-06-01 2024-05-31 13406862 frs-bus:SmallEntities 2023-06-01 2024-05-31 13406862 frs-bus:AuditExempt-NoAccountantsReport 2023-06-01 2024-05-31 13406862 frs-bus:SmallCompaniesRegimeForAccounts 2023-06-01 2024-05-31 13406862 frs-core:ListedExchangeTraded 2024-05-31 13406862 frs-core:ListedExchangeTraded 2023-05-31 13406862 frs-core:CostValuation frs-core:ListedExchangeTraded 2023-05-31 13406862 frs-core:AdditionsToInvestments frs-core:ListedExchangeTraded 2024-05-31 13406862 frs-core:CostValuation frs-core:ListedExchangeTraded 2024-05-31 13406862 frs-core:ProvisionsForImpairmentInvestments frs-core:ListedExchangeTraded 2023-05-31 13406862 frs-core:ProvisionsForImpairmentInvestments frs-core:ListedExchangeTraded 2024-05-31 13406862 frs-bus:Director1 2023-06-01 2024-05-31 13406862 frs-bus:Director2 2023-06-01 2024-05-31 13406862 frs-countries:EnglandWales 2023-06-01 2024-05-31 13406862 2022-05-31 13406862 2023-05-31 13406862 2022-06-01 2023-05-31 13406862 frs-core:CurrentFinancialInstruments 2023-05-31 13406862 frs-core:Non-currentFinancialInstruments 2023-05-31 13406862 frs-core:ShareCapital 2023-05-31 13406862 frs-core:RetainedEarningsAccumulatedLosses 2023-05-31
Registered number: 13406862
Visure Ophthalmics Ltd
Unaudited Financial Statements
For The Year Ended 31 May 2024
Anderson Ross Accounting & Tax Ltd
G-05 Davenport House
16 Pepper Street
London
E14 9RP
Contents
Page
Balance Sheet 1—2
Notes to the Financial Statements 3—4
Page 1
Balance Sheet
Registered number: 13406862
2024 2023
Notes £ £ £ £
FIXED ASSETS
Investments 4 23,808 -
23,808 -
CURRENT ASSETS
Debtors 5 5 5
Cash at bank and in hand 100 100
105 105
Creditors: Amounts Falling Due Within One Year 6 (25,763 ) (1,205 )
NET CURRENT ASSETS (LIABILITIES) (25,658 ) (1,100 )
TOTAL ASSETS LESS CURRENT LIABILITIES (1,850 ) (1,100 )
NET LIABILITIES (1,850 ) (1,100 )
CAPITAL AND RESERVES
Called up share capital 7 100 100
Profit and Loss Account (1,950 ) (1,200 )
SHAREHOLDERS' FUNDS (1,850) (1,100)
Page 1
Page 2
For the year ending 31 May 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board
Mr Max Baumann
Director
17 February 2025
The notes on pages 3 to 4 form part of these financial statements.
Page 2
Page 3
Notes to the Financial Statements
1. General Information
Visure Ophthalmics Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 13406862 . The registered office is G-05 Davenport House, 16 Pepper Street, London, , E14 9RP.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
3. Average Number of Employees
Average number of employees, including directors, during the year was: 2 (2023: 2)
2 2
4. Investments
Listed
£
Cost
As at 1 June 2023 -
Additions 23,808
As at 31 May 2024 23,808
Provision
As at 1 June 2023 -
As at 31 May 2024 -
Net Book Value
As at 31 May 2024 23,808
As at 1 June 2023 -
5. Debtors
2024 2023
£ £
Due after more than one year
Other debtors 5 5
6. Creditors: Amounts Falling Due Within One Year
2024 2023
£ £
Other creditors 24,813 605
Accruals and deferred income 950 600
25,763 1,205
Page 3
Page 4
7. Share Capital
2024 2023
£ £
Allotted, Called up and fully paid 100 100
Page 4